These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28249264)

  • 21. Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis.
    Sasaki M; Nakanuma Y
    Hepat Res Treat; 2010; 2010():205128. PubMed ID: 21152179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
    Erice O; Munoz-Garrido P; Vaquero J; Perugorria MJ; Fernandez-Barrena MG; Saez E; Santos-Laso A; Arbelaiz A; Jimenez-Agüero R; Fernandez-Irigoyen J; Santamaria E; Torrano V; Carracedo A; Ananthanarayanan M; Marzioni M; Prieto J; Beuers U; Oude Elferink RP; LaRusso NF; Bujanda L; Marin JJG; Banales JM
    Hepatology; 2018 Apr; 67(4):1420-1440. PubMed ID: 28922472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Abnormal expression of pyruvate dehydrogenase on bile ducts opens new fields in the pathogenesis of primary biliary cirrhosis].
    Nakanuma Y; Yasoshima M; Morita T; Gershwin ME
    Nihon Rinsho; 1995 May; 53(5):1287-96. PubMed ID: 7602793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.
    Sasaki M; Nakanuma Y
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):129-138. PubMed ID: 27618480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection.
    Trampert DC; Kersten R; Tolenaars D; Jongejan A; van de Graaf SFJ; Beuers U
    JHEP Rep; 2024 Apr; 6(4):101015. PubMed ID: 38524667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection.
    Herta T; Kersten R; Chang JC; Hubers L; Go S; Tolenaars D; Paulusma CC; Nathanson MH; Elferink RO; van de Graaf SFJ; Beuers U
    J Hepatol; 2022 Feb; 76(2):319-331. PubMed ID: 34718050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis.
    Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
    Dig Dis Sci; 2012 Mar; 57(3):660-6. PubMed ID: 21989821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased p16
    Sasaki M; Sato Y; Nakanuma Y
    J Autoimmun; 2020 Feb; 107():102377. PubMed ID: 31812332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
    Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
    Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids.
    Kersten R; Trampert DC; Hubers LM; Tolenaars D; Vos HR; van de Graaf SFJ; Beuers U
    Front Immunol; 2023; 14():1251134. PubMed ID: 38332916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss.
    Sasaki M; Ikeda H; Haga H; Manabe T; Nakanuma Y
    J Pathol; 2005 Mar; 205(4):451-9. PubMed ID: 15685690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis.
    Chen R; Tang R; Ma X; Gershwin ME
    Clin Liver Dis; 2022 Nov; 26(4):583-611. PubMed ID: 36270718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Emerging Role of Soluble Adenylyl Cyclase in Primary Biliary Cholangitis.
    Chang JC; Beuers U; Oude Elferink RP
    Dig Dis; 2017; 35(3):217-223. PubMed ID: 28249274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.
    Ma WT; Liu QZ; Yang JB; Yang YQ; Zhao ZB; Ma HD; Gershwin ME; Lian ZX
    Sci Rep; 2017 Nov; 7(1):15246. PubMed ID: 29127360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary biliary cholangitis: primary autoimmune disease or primary secretory defect.
    Floreani A; Gabbia D; De Martin S
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):863-870. PubMed ID: 37515436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation.
    Etherington RE; Millar BJM; Innes BA; Jones DEJ; Kirby JA; Brain JG
    FASEB Bioadv; 2019 May; 1(5):332-343. PubMed ID: 32123836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Sasaki M; Sato Y; Nakanuma Y
    Clin Res Hepatol Gastroenterol; 2023 Apr; 47(4):102106. PubMed ID: 36849079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes.
    Komichi D; Tazuma S; Nishioka T; Hyogo H; Une M; Chayama K
    Dig Dis Sci; 2003 Dec; 48(12):2315-22. PubMed ID: 14714619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.